MYD88 and rosacea: The molecular mechanisms driving mast cell activation in rosacea remain poorly understood, though recent studies highlight the involvement of two key signaling pathways: the TLR2/MyD88 pathway and the Janus kinase/signal transducer and activator of transcription (JAK/STAT) pathway.